WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018053073) METHOD OF USE OF ERITORAN AS A TLR4 ANTAGONIST FOR TREATMENT OF EBOLA AND MARBURG DISEASE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/053073    International Application No.:    PCT/US2017/051472
Publication Date: 22.03.2018 International Filing Date: 14.09.2017
IPC:
A61K 31/00 (2006.01), A61K 31/7024 (2006.01), A61P 31/14 (2006.01)
Applicants: EISAI R&D MANAGEMENT CO., LTD. [JP/JP]; 6-10 Koishikawa, 4-chome, Bunkyo-ku Tokyo, 112-8088 (JP).
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM [US/US]; 201 West Seventh Street Austin, Texas 78701 (US)
Inventors: BUKREYEV, Alexander; (US).
GUSOVSKY, Fabian; (JP).
YOUNAN, Patrick; (US).
EVERSON, Michael; (JP)
Agent: WALTERS, Todd R.; (US).
STEWART, Duane A., III; (US).
MARKOWSKI, Mythili; (US)
Priority Data:
62/395,694 16.09.2016 US
62/452,778 31.01.2017 US
Title (EN) METHOD OF USE OF ERITORAN AS A TLR4 ANTAGONIST FOR TREATMENT OF EBOLA AND MARBURG DISEASE
(FR) PROCÉDÉ D'UTILISATION D'ÉRITORAN EN TANT QU'ANTAGONISTE DE TLR4 POUR LE TRAITEMENT DE LA MALADIE À VIRUS EBOLA ET LA MALADIE DE MARBURG
Abstract: front page image
(EN)The present invention is directed to methods for treating ebola virus infections or Marburg virus infections comprising administering to a subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
(FR)L'invention concerne des méthodes de traitement d'infections par le virus Ebola qui consistent à administrer à un sujet une quantité efficace d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)